CounterPath (CPAH) Lowered to Hold at Zacks Investment Research

CounterPath (NASDAQ:CPAH) (TSE:CCV) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “CounterPath, Corp. focuses on the design, development, marketing and sales of desktop and mobile application software, conferencing server software, gateway server software and related professional services, such as pre and post sales technical support and customization services. The Company’s software products are sold into the telecommunications sector, specifically the voice over Internet protocol, unified communications and fixed-mobile convergence markets. The company’s product suite includes SIP-based softphones, server applications and Fixed Mobile Convergence solutions that enable service providers, enterprises and Original Equipment Manufacturers to cost-effectively integrate voice, video, presence and Instant Messaging applications into their VoIP offerings and extend functionality across both fixed and mobile networks. This company is covered under both TSX and NYSE as V.CCV and CPAH respectively. “

Separately, ValuEngine downgraded CounterPath from a “sell” rating to a “strong sell” rating in a report on Sunday, December 31st.

Shares of CounterPath (NASDAQ CPAH) traded up $0.03 during trading hours on Tuesday, hitting $3.69. The stock had a trading volume of 17,986 shares, compared to its average volume of 207,163. CounterPath has a 1 year low of $1.75 and a 1 year high of $7.30. The company has a market capitalization of $19.81, a P/E ratio of -7.24 and a beta of -0.30.

In related news, Director Steven Bruk purchased 125,000 shares of CounterPath stock in a transaction dated Wednesday, January 24th. The stock was purchased at an average cost of $4.01 per share, for a total transaction of $501,250.00. Following the completion of the acquisition, the director now directly owns 1,045,953 shares of the company’s stock, valued at $4,194,271.53. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. 38.30% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “CounterPath (CPAH) Lowered to Hold at Zacks Investment Research” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/02/13/counterpath-cpah-lowered-to-hold-at-zacks-investment-research.html.

CounterPath Company Profile

CounterPath Corporation designs, develops and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol (IP)-based networks.

Get a free copy of the Zacks research report on CounterPath (CPAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CounterPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CounterPath and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply